Foghorn Therapeutics Inc (FHTX) — Free Cash Flow Generation Index

Latest as of March 2022: 1.00x

Foghorn Therapeutics Inc (FHTX) has a Free Cash Flow Generation Index of 1.00x as of March 2022. Free cash flow of $271.29 Million represents 1% of operating cash flow ($271.53 Million). See working capital to net assets of Foghorn Therapeutics Inc to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$271.29 Million
USD

Operating Cash Flow

$271.53 Million
USD

Capital Expenditures

$247.00K
USD

Foghorn Therapeutics Inc Free Cash Flow Generation Index (2022–2022)

Historical FCF Generation Index trend for Foghorn Therapeutics Inc across 1 annual periods. Explore debt repayment capacity of Foghorn Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Foghorn Therapeutics Inc (2022–2022)

Year-by-year Free Cash Flow Generation Index for Foghorn Therapeutics Inc. For the full company profile including market capitalisation, see Foghorn Therapeutics Inc (FHTX) total market value.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2022 0.99x $192.40 Million $193.61 Million $1.21 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).